Capital allocation failures are not just the result of bad individual decisions by overconfident CEOs. They are, in many cases, the predictable output of organizational systems and processes that are structurally designed to produce poor capital allocation outcomes.
The way most companies evaluate capital investment proposals, run M&A processes, and make budgeting decisions contains systematic distortions that lead good people to make bad capital allocation choices — not because they lack intelligence, but because the process itself has removed the conditions under which good decisions could be made.
This is the second post in a three-part series on capital allocation failure. This piece examines how the process itself — not just individual psychology — creates the conditions for value destruction.
The Fundamental Process Problem: All Capital Is Treated the Same
Every company, without exception, runs a capital allocation process. Finance teams develop investment proposals. Executives present them. Committees review them. Boards approve them. The process looks rigorous. It is also almost always deeply flawed — because it treats fundamentally different types of capital decisions as if they require the same analytical framework.
Consider four categorically different capital decisions:
A venture capital-style investment in an early-stage product line, where the probability of success is low and the outcome distribution is highly skewed. A maintenance capital expenditure to replace a piece of equipment in an existing factory. An acquisition of a mature, stable cash-flowing business. A buyback of the company’s own shares at a specific valuation.
These four decisions require completely different analytical frameworks, different hurdle rates, and different decision-making processes. The probability-weighted return calculation that is appropriate for the VC investment is useless for the maintenance capex decision. The DCF model that is appropriate for the acquisition is completely wrong for the share buyback. The heuristic that is appropriate for the buyback is inadequate for the VC investment.
Yet most companies subject all four to versions of the same process: a finance team builds a model, a committee reviews it, a hurdle rate is applied, and a recommendation is made. The fundamental error is in treating fundamentally different types of capital decisions as equivalent.
The CFO vs. CEO Problem
The standard capital allocation process separates the analytical work — done by the CFO and finance team — from the strategic judgment — exercised by the CEO and board. This separation sounds logical. In practice, it creates a systematic failure mode.
The CFO’s job, as typically structured, is to make the numbers work. Given a proposed investment, the CFO’s team builds a financial model — projections of revenue, costs, synergies, and cash flows. They stress-test assumptions. They present a range of outcomes. They calculate an NPV or IRR against the company’s hurdle rate. The output of the CFO’s process is a recommendation that is framed in the language of financial analysis.
The CEO’s job is to make the strategic decision. Given the financial analysis, the CEO must evaluate the non-quantifiable factors: what this acquisition does to the company’s competitive position, what refusing an investment does to organizational morale, what the deal means for the company’s strategic optionality. This is a fundamentally different type of judgment.
The problem is that the financial model’s apparent precision creates an anchor for the CEO’s decision. When the CFO presents a detailed financial model with specific NPV projections, the CEO faces enormous pressure to accept the model’s conclusions. The model looks scientific. It has precise numbers. The CEO who says “I don’t trust the model” sounds like they are avoiding responsibility. The CEO who accepts the model’s conclusions can point to the analysis if it goes wrong.
What the model cannot capture — and what the CEO must judge independently — is the quality of the assumptions embedded in the model. Every financial model is only as good as the assumptions it contains. The assumptions about market growth rates, competitive dynamics, integration costs, synergy realization timelines, and terminal values are almost always optimistic, because the people building the model are motivated to find a financial justification for decisions that have already been made for strategic reasons.
The most dangerous phrase in corporate capital allocation is: “the model supports the deal.” This phrase has preceded some of the largest value-destroying acquisitions in corporate history. The model always supports the deal, because the model was built by people who were asked to find whether the deal works — not whether the deal is a good use of capital.
The Kill-the-Project Problem
In almost every company, there is a significant asymmetry between the investment required to start a project and the investment required to kill one. Getting approval for a new capital project requires a detailed financial proposal, a business case, and committee sign-off. Killing an approved project requires exactly the same thing — except that killing an approved project means admitting that the original approval was wrong.
This asymmetry has a name in corporate finance: the “prospective capital rationing” problem. Once capital has been allocated, it is much harder to reallocate. The sunk cost psychology described in the first post operates at the organizational level, not just the individual level. The project team that received approval has already hired staff, signed supplier contracts, and made career commitments to the project’s success. Presenting a kill recommendation means telling your own colleagues that their work has been for nothing.
The result is a systematic bias toward continuing approved projects that should be killed. In theory, capital allocation processes should include formal annual reviews of all approved projects, with a genuine willingness to reallocate capital from underperforming investments. In practice, this almost never happens at the scale required. The annual budget process allocates incremental capital but rarely examines whether previously allocated capital should continue.
McKinsey’s research found that the most capital-intensive reviews — the quarterly and annual capital allocation meetings — focus almost entirely on new investment proposals. The question “should we continue to fund this existing project?” is almost never on the agenda with the same rigor as “should we approve this new project?” This asymmetry means that capital continues to flow to projects that have already failed their original thesis, while genuinely promising new opportunities are underfunded.
The Operational Budget vs. Capital Allocation Confusion
Most large companies use a single annual budget process to handle both operational expenses and capital allocation decisions. This is a serious mistake — these are fundamentally different types of decisions requiring different processes.
Operational budgets are about efficiency: given the capital we have committed to this activity, how efficiently are we using it? Capital allocation decisions are about efficacy: should we be committing capital to this activity at all? These questions require different analytical frameworks, different time horizons, and different decision-makers.
The operational budget process creates a bias toward incremental improvement of existing activities rather than genuine capital allocation choices. Division managers are rewarded for spending their allocated capital budgets — not for returning unneeded capital to the center. A division that underspends its capital budget in a given year is likely to receive a smaller budget the following year, because the baseline has been reduced. This creates a structural incentive to spend allocated capital regardless of whether the investment creates genuine value.
The companies that do capital allocation well — including Danaher, whose capital allocation process is widely studied — treat capital allocation as a completely separate process from operational budgeting. Capital allocation decisions are made by a dedicated senior team, with a multi-year return horizon, reviewed quarterly against original thesis, and insulated from the short-term operational budget process.
The Board Approval Problem
Boards of directors are responsible, in theory, for rigorously reviewing major capital allocation decisions. In practice, board capital allocation oversight is significantly compromised by structural limitations.
Board members are not full-time employees of the company. They are typically senior executives or professionals with significant outside commitments. The time available to evaluate a major acquisition proposal — which might be a $2 billion decision affecting the company’s future — is limited to a few board meetings and a due diligence process that is managed by the same management team that wants to do the deal.
The information asymmetry between management and the board is enormous. Management has spent months living with the deal. Board members receive a presentation and a CIM (Confidential Information Memorandum) and are expected to reach a decision in a limited number of meeting hours. The management team, whose careers are tied to the success of the deal, has an enormous informational advantage over independent directors who are evaluating it.
Board members also face their own behavioral challenges. Most board members are current or former CEOs themselves. They have personal relationships with the CEO proposing the deal. They are naturally deferential to management expertise in areas outside their own domain. The board member who asks the difficult questions about whether this acquisition is the right use of capital is often viewed as a problem by management — not as a diligent fiduciary.
The result is that board approval of major capital allocation decisions has become, in many companies, a ratification of management’s recommendation rather than an independent evaluation of alternatives. The board process provides legal cover for the decision — a bad acquisition approved by a board is harder to sue over than an unauthorized one — without providing the independent scrutiny that capital allocation decisions require.
The Compensation Structure That Rewards the Wrong Things
CEOs and senior executives are paid, in most companies, based on a combination of revenue growth, EBITDA margin, and total shareholder return relative to a peer group. Each of these metrics creates a specific capital allocation incentive that is misaligned with long-term value creation.
Revenue growth incentives create empire-building incentives. An executive whose compensation is tied to revenue growth will naturally favor acquisitions that expand the top line — regardless of the return on capital — over organic growth in the existing business. An acquisition that adds $200 million in revenue at a 5% margin is worse for the business than organic growth in a 25% margin business, but may generate a larger compensation payout for the executive.
Total shareholder return relative to a peer group creates the benchmark trap described in the first post. An executive whose compensation is tied to TSR relative to peers will make capital allocation decisions that keep them close to the peer group — even if the peer group is collectively overpaying for acquisitions or investing in the wrong sectors.
The most dangerous compensation structure is one that rewards deal volume. Executives who are paid bonuses tied to the number or size of acquisitions have a direct financial incentive to do deals — regardless of whether those deals create value. The solution — tying compensation explicitly to returns on invested capital, rather than deal size or revenue growth — is well understood and rarely implemented, because it is harder to manipulate and harder to achieve.
The Process Solutions That Actually Work
The third post in this series will examine the specific frameworks that excellent capital allocators use — but the process fixes for the structural problems identified here are worth noting.
Separate the capital allocation process from the operational budgeting process entirely. Capital allocation decisions should be reviewed quarterly, against the original investment thesis, by a dedicated senior committee that has no operational reporting line.
Hold capital allocation decisions to the same standard as the original approval. A project that is underperforming its original thesis should face the same scrutiny as a new investment proposal — with an explicit willingness to reallocate rather than to continue investing.
Make board capital allocation oversight genuinely independent. Board members who have personal or professional relationships with management should recuse themselves from relevant decisions. Independent financial advisors, not management-controlled processes, should drive board-level due diligence.
Compensate based on return on invested capital, not deal size or revenue growth. The metrics that drive compensation will drive behavior. If the compensation committee is serious about capital discipline, the metrics must reflect it.
The third and final post in this series examines the specific frameworks that the world’s best capital allocators actually use — and how to build the organizational culture and discipline that makes them sustainable.